The Hague, 13 February 2018. The Head of the Business of Msc. Norkis Arteaga Morales made a working visit to the Netherlands to explore investment opportunities between Cuba and Dutch companies of the biotechnology and pharmaceutical sector as well as for the commercialization of cuban biotechnological products in the Dutch and European markets.
The programme included meetings in 4 Dutch cities with representatives of companie sof the sectgtor, the National Drug Authority, the bioscience and innovation cluster, as well as BioScience training and consultancy agencies.
The visit was also a good opportunity to showcase Cuba's groundbreaking and poisitive results in the production of drugs for oncological use and other diseases, such as Heberprot-P, which is used to treat diabetic foot.
During the visit, it was also presente the business opportunities portfolio of BioCubaFarma and the Business Forum of the BioPharmaceutical Industry , which will be held as part of the "Salud para todos" International Fair on April 24 in Havana.
The Netherlands will be the base of the European Medicines Agency (EMA) starting in March 2019.
(Embacuba Paises Bajos/Cubaminrex)